メインコンテンツに移動

Caveat creator: GenAI giants’ pledges won’t pre-empt copyright suits

Tech vendors offer indemnities on generative output, but end-users need to check the fine print, warn IP lawyers

Copyright

One year after Wall Street banned the use of generative artificial intelligence (GenAI) bots, the prevailing defensive stance towards the technology has shifted to one of active exploration.

Even banks – known for their conservatism and risk aversion – are now racing to experiment with hundreds of use cases. Some are already opening up access to GenAI’s possibilities to large numbers of employees.

B

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

無料メンバーシップの内容をお知りになりたいですか?ここをクリック

パスワードを表示
パスワードを非表示にする

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here